Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Am J Cardiol. 2016 Jun 14;118(5):684–690. doi: 10.1016/j.amjcard.2016.06.016

Table 1.

Characteristics of participants (COHORT A) at baseline stratified by presence of echocardiographic left ventricular hypertrophy

Characteristic No LVH (N = 2272) LVH (N = 305)
Age (years) 71.9 (5.0) 73.2 (5.6)
Black race (N, %) 342 (15.1%) 39 (12.8%)
Male sex (N, %) 779 (34.3%) 160 (52.5%)
Total cholesterol (mg/dl) 215.2 (38.7) 204.5 (35.6)
Systolic blood pressure (mm Hg) 135 (20) 143 (24)
High-density lipoprotein cholesterol (mg/dl) 56.6 (15.8) 54.0 (15.8)
Electrocardiographic left ventricular mass (g) 147.1 (27.4) 164.1 (39.4)
Echocardiographic left ventricular mass (g) 134.7 (33.3) 224.7 (49.8)
Anti-hypertensive medication (N, %) 798 (35.1%) 146 (47.9%)
Current smoker (N, %) 262 (11.5%) 47 (15.4%)
Diabetes mellitus (N, %) 264 (11.6%) 50 (16.4%)

All values expressed as mean (SD) or N(%)

LVH = left ventricular hypertrophy